The Non-Financial Ledger

Picture March 2020. You’re standing in a drugstore aisle that’s been stripped bare. The disinfectant shelves look like a photo from a post-apocalyptic movie. Your hands are cracked from the cheap hand sanitizer you found at a gas station. You have elderly parents. You have kids. You are scared, and that fear is entirely rational, because people are dying and nobody seems to have any real answers.

Now picture finding a product online that promises, in plain English, that it is “Safe formulation is effective against Corona.” Not “may help.” Not “use as part of a cleaning routine.” Effective. Against. Corona. You click add to cart. You pay. You trust it.

What Ginesis Natural Products was selling you during that period was a product that had never gone through the federal registration process designed specifically to verify that those claims are true. The EPA’s registration requirement for pesticides and antimicrobials is not bureaucratic red tape. It is the checkpoint that forces a company to prove, with real data, that a product actually does what it says it does and that it is safe to use. Ginesis skipped that checkpoint entirely and kept selling anyway.

The Ginesis Antimicrobial product was sold and distributed from at least August 17, 2020. That is five months into a global pandemic. The company’s own website was still advertising it as late as March 2023 — nearly three full years of uninterrupted sales during which customers had no independent verification that a single claim on that label or website was true. The “effective against Corona” claim was advertising to people at their most vulnerable. Sick. Grieving. Desperate not to bring the virus home.

The lice spray tells a different story, but the same pattern. Parents buying lice repellent for their kids have a right to know what is actually in the bottle, what percentage, and whether it has been evaluated. The Nit Free Mint Repelling Lice Spray label did not disclose the name or percentage of its active ingredients. You were told it used “natural peppermint oil” to repel lice. You were not told how much. You were not given any federally reviewed evidence that it worked. You put it on your child’s hair anyway, because the label said it would protect them.

Neither of these products were recalled. There is no public record in this document of anyone being harmed by them. But the entire premise of the registration law is that you don’t wait to find out. You verify first. Ginesis chose revenue over that process, and the people who paid for these products during some of the most frightening years of recent memory deserved better than a company’s unverified word.

“Effective against Corona” — written on an unregistered product, sold during a pandemic, to people who had no way of knowing the claim had never been federally verified.

Legal Receipts: What the Document Actually Says

The following are direct quotes from the EPA Consent Agreement and Final Order, Docket No. FIFRA-04-2024-3020(b), filed May 13, 2025. These are not paraphrases.

“The website displayed certain pesticidal claims being made for Ginesis Antimicrobial, including: ‘inactivates viruses and bacteria’ and ‘Safe formulation is effective against Corona’.”

“The label collected during the inspection for the Ginesis Antimicrobial product bore the following pesticidal claims: (a) ‘Inactivates viruses and bacteria;’ (b) ‘To treat bacteria on hard surfaces let stand for 10 minutes;’ (c) ‘To treat bacteria on fabrics spot treat;’ and (d) ‘To sanitize: let stand for 30 seconds and then allow to air dry.'”

“The Ginesis Antimicrobial product label collected during the inspection included statements that the product was exempt from FIFRA registration as a minimum risk pesticide. However, because the product label and website labeling bore specific claims that the product could control or mitigate microorganisms (bacteria and viruses) that pose a threat to human health, the product did not meet the minimum risk pesticide requirement…”

“The sales records collected during the inspection showed that Respondent sold and distributed the Ginesis Antimicrobial product on one or more occasions between August 17, 2020, and December 12, 2022. Additionally, the product was being offered for sale on Respondent’s website at the time of the EPA’s website review on March 27, 2023.”

“EPA’s examination of the Nit Free Mint Repelling Lice Spray product label and website labeling revealed that this product did not display the name and percentage of each active ingredient, thus did not meet the minimum risk pesticide requirement…”

“Respondent: (b) neither admits nor denies the specific factual allegations set forth in Section IV (Findings of Facts) of this CAFO…”

Societal Impact Mapping

Public Health

The registration requirement Ginesis bypassed exists because antimicrobial products touch the most vulnerable moments in human life. These harms are structural, not hypothetical.

• People relying on an unverified “effective against Corona” claim during the COVID-19 pandemic may have believed they were protected from surface transmission when they were not. Behavioral decisions made on false safety assurances carry real consequences during a disease outbreak.
• The EPA registration process for antimicrobial pesticides requires a company to submit scientific data demonstrating efficacy against the specific pathogens claimed on the label. Ginesis never submitted that data, meaning no independent scientist ever reviewed whether its product actually inactivated viruses or bacteria at the concentrations and contact times specified on the label.
• The Nit Free Mint Repelling Lice Spray was used on children’s scalps. Because the label did not disclose active ingredient names or concentrations, parents and pediatricians had no way to assess whether the product was safe for children with allergies or sensitivities, or whether it interacted with other products being applied to a child’s hair.
• Lice infestations disproportionately affect school-age children in lower-income households where access to professional treatment is limited. Parents relying on an accessible over-the-counter option marketed as effective deserve the assurance that the product has been evaluated. That assurance was never available here.

Economic Inequality

The people most likely to buy a “natural” antimicrobial spray with COVID claims or an affordable lice repellent are the people with the fewest backup options. The economic stakes of this pattern fall hardest on them.

• Consumers who purchased Ginesis Antimicrobial during the pandemic paid money for a product marketed with specific, detailed safety claims. Those claims were never validated. The purchase price bought reassurance that was not backed by any federal evaluation.
• If customers used the unregistered Ginesis Antimicrobial in place of a registered, EPA-evaluated disinfectant, they may have left surfaces inadequately sanitized while believing otherwise. The cost of that substitution cannot be measured in dollars.
• The $45,000 penalty imposed on Ginesis is a one-time cost to a corporation. The consumers who bought the product during a multi-year period received no refunds, no notification, and no acknowledgment from the company that the product they purchased had never been through the federal verification process it implied it had.
• Small businesses and competitors who properly registered their antimicrobial products incurred the significant cost and time of EPA compliance. Ginesis competed in that market without bearing those costs, creating an uneven playing field where doing the right thing put compliant companies at a financial disadvantage.

The Cost of a Life Metric

What Now?

The enforcement action is closed. The fine has been paid. But the people and institutions with ongoing authority over Ginesis and operations like it remain active. Here is where accountability continues to exist.

Corporate Leadership Named in This Document

• Jeff Hester, President, Ginesis Natural Products — listed in the Certificate of Service as the company contact for this enforcement action. As president, he holds responsibility for the product decisions and labeling practices documented in this case.

Watchlist: Regulatory Bodies with Ongoing Authority

• EPA Region 4 (Atlanta) — the regulating body that brought this action. Under the terms of the CAFO, this enforcement action counts as part of Ginesis’s compliance history in any future proceedings. One more violation, and the baseline is higher.
• U.S. Environmental Protection Agency, Office of Pesticide Programs — the national body responsible for FIFRA registration and enforcement standards. Any future unregistered pesticide sale by Ginesis would be a repeat offense.
• Federal Trade Commission (FTC) — the FTC holds authority over deceptive advertising practices. COVID-related health claims made without substantiation fall squarely in their enforcement territory, separate from EPA’s pesticide authority.
• Alabama Attorney General’s Office / Alabama Department of Agriculture and Industries — state-level consumer protection and agricultural enforcement may have independent authority over misleading product claims made to Alabama residents.

What You Can Actually Do

• If you purchased Ginesis Antimicrobial or Nit Free Mint Repelling Lice Spray during the violation period, you have the right to file a consumer complaint with the EPA’s enforcement tip line and with your state attorney general’s consumer protection office. Your complaint becomes part of the record that regulators consult when evaluating future enforcement actions.
• Check every antimicrobial or pest-control product you own against the EPA’s registered pesticide database, searchable at epa.gov/pesticide-registration. If a product claims to disinfect, sanitize, kill bacteria, or repel insects or pests, it should appear in that database. If it does not, report it.
• Share this enforcement record in parenting communities, health forums, and mutual aid networks where people make purchasing decisions about disinfectants and pest control products. The most powerful check on this behavior is an informed consumer base that knows how to verify registration status before buying.
• Support organizations advocating for stronger penalty structures under FIFRA. A $45,000 fine for four years of unregistered pesticide sales — including pandemic-era COVID claims — does not deter a company unless the fine exceeds the revenue generated. Advocacy for penalty reform is direct, practical organizing that changes the calculus for future violators.
• If you are part of a school, daycare, or community health organization, build a verification step into your product procurement process. Require that any antimicrobial or pest-control product used in your facility have a visible EPA registration number before purchase. That single step closes the door on unregistered products entering spaces where children and vulnerable people are present.